A 68-year-old male patient underwent transurethral microwave thermotherapy for benign prostatic hyperplasia (BPH) six weeks ago. During a planned follow-up within that global window (90 days), the same physician performs the insertion of a temporary prostatic urethral stent due to urinary retention. How is the insertion of a temporary prostatic urethral stent reported? ...
Subscribe or sign in to view the full article.
Article Overview
The article examines a urology follow-up scenario involving a temporary prostatic urethral stent after transurethral microwave thermotherapy for benign prostatic hyperplasia. It covers global-period reporting considerations, the relationship between the follow-up procedure and the earlier treatment, and historical code-set context.
Why This Topic Matters
Understanding the topics covered can help coding and billing professionals assess how postoperative procedures and global-period considerations are addressed in urology cases.
What You Will Learn
- The reporting topics associated with temporary prostatic urethral stent insertion during postoperative follow-up.
- How the article frames the relationship between a follow-up procedure and an earlier BPH treatment.
- Historical context for the codes discussed.
- intended_audiences
Who Should Read This
- Medical coders
- Urology billing and coding professionals
- Urologists and other clinicians involved in BPH care
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com